SecBot SecBot
PRESS-RELEASE ·Filed Apr 22, 2026

ACON

Aclarion, Inc.
NEUTRAL
Impact 3/10
Horizonmonths Processed6mo ago WireGlobeNewswire
Press release · Buyback
Actionable Insight • Neutral

Monitor for actual repurchase activity under Rule 10b5-1 plans or periodic 10-Q filings for execution updates. Given the small market cap, even modest repurchases could move the stock, but absence of mandatory commitment limits immediate upside.

DirectionNeutral
Confidencehigh
Horizonmonths
Final — all horizons settled through T+60d
ACON ▼ -30.83% at T+60d
NEUTRAL call -30.83% · α vs SPY -35.61% · entry $3.73 → $2.58
Entry = T+0 close
Apr 22, 2026
via day close
T+1d
-12.60%
call -12.60% · α -12.21%
$3.26
settled 6mo ago
T+5d
-12.68%
call -12.68% · α -12.74%
$3.26
settled 6mo ago
T+20d
-14.21%
call -14.21% · α -17.37%
$3.20
settled 5mo ago
T+60d
-30.83%
call -30.83% · α -35.61%
$2.58
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Aclarion, Inc. announced a $2.5 million share repurchase program, funded by existing cash, to enhance shareholder value amid claims of undervaluation. The program is discretionary and may be modified or paused at any time.

Key Financial Metrics

Deal Value
$2.5M

Key Facts

  • Aclarion authorized a $2.5 million share repurchase program.
  • Repurchases will be funded using existing cash and cash equivalents of $19.0 million as of March 31, 2026.
  • The program is expected to be executed over the next 12 months but is not mandatory and may be suspended or discontinued.
  • No specific number of shares will be repurchased; methods include open market purchases, privately negotiated transactions, or Rule 10b5-1 plans.

Financial Impact

$2.5 million, representing approximately 31% of market cap ($8M) if fully deployed.

dilutioncash

Risk Factors

  • Program is discretionary and may not result in any actual repurchases.
  • Limited financial impact given small size relative to cash reserves and market cap.

Market Snapshot

Exchange
Nasdaq
Sector
Services-Medical Laboratories

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3278958
10 reports for ACON
Performance horizon
33% Hit rate @ T+20 1 of 3 directional calls Went positive at some point 2 of 3 best @ T+1▲ +6.54%Aug 18, 2026
Filters
Rows
Reports for ACON — sortable, filterable
TypeNow
Aug 19, 2026
9w ago
Insider Cluster
BULLISH ★ 7/10
$2.77 $2.64▼ −4.69%▼ −2.74%$1.95 (−29.60%)
Aug 18, 2026
10w ago
Insider Cluster
BULLISH ★ 6/10
$2.60 $2.53▼ −2.67%▼ −1.68%$1.95 (−25.00%)
Jun 9, 2026
20w ago
Press Release
NEUTRAL ★ 3/10
$3.26 $2.99▼ −8.28%▼ −9.73%$1.95 (−40.18%)
Jun 8, 2026
20w ago
Press Release
MIXED ★ 6/10
$3.36 $3.07▼ −8.63%▼ −10.26%$1.95 (−41.96%)
Jun 3, 2026
20w ago
Press Release
NEUTRAL ★ 4/10
$3.49 $3.09▼ −11.46%▼ −10.46%$1.95 (−44.13%)
Jun 1, 2026
21w ago
Press Release
NEUTRAL ★ 3/10
$3.37 $2.88▼ −14.54%▼ −13.24%$1.95 (−42.14%)
May 6, 2026
24w ago
Insider Cluster
BULLISH ★ 6/10
$3.28 $3.49▲ +6.40%▲ +3.62%$1.95 (−40.55%)
May 5, 2026
25w ago
Press Release
NEUTRAL ★ 4/10
$3.20 $3.50▲ +9.38%▲ +4.42%$1.95 (−39.06%)
Apr 22, 2026
26w ago
Press Release
NEUTRAL ★ 3/10
$3.73 $3.20▼ −14.21%▼ −17.37%$1.95 (−47.72%)
Mar 19, 2026
31w ago
Press Release
NEUTRAL ★ 4/10
$3.26 $3.39▲ +3.99%▼ −3.63%$1.95 (−40.18%)
Showing 10 of 10

US Market Status

Market Open — Closes in 4h 20m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 22, 2026